Patient no. | Age (years) | Follow-up (months) | Procedure | Location | Maximum diameter base (mm) | Height (mm) | VA preop | VA final | Brachytherapy (associated) | Local recurrence | Enucleation | Metastasis | Death | Notes | Complications |
1 | 37 | 129 | Primary | IN | 7 | 8.5 | 0.63 | 0.05 | No | No | No | No | No | No | |
2 | 29 | 128 | Primary | N | 6 | 8.5 | 1 | NLP | Yes | No | Yes | No | No | Phthisis | |
3 | 52 | 120 | Primary | T | 10 | 12 | 0.1 | HM | No | No | No | No | No | No | |
4 | 34 | 116 | Primary | N | 12.7 | 11.8 | 0.67 | 0.08 | No | No | No | No | No | No | |
5 | 43 | 114 | Primary | I | 12.5 | 11.1 | 0.25 | 0.05 | No | No | No | No | No | SRNM | |
6 | 59 | 108 | Primary | ST | 5.5 | 12 | 0.4 | 0.2 | No | No | No | No | No | RD | |
7 | 74 | 106 | Primary | T | 14 | 11.2 | 0.4 | 0.63 | No | No | No | No | No | ERM | |
8 | 65 | 98 | Primary | T | 10 | 12 | HM | CF | No | No | No | No | No | RD | |
9 | 43 | 96 | Primary | YP | 11.8 | 10.3 | 0.63 | 0.2 | No | No | No | No | No | ERM | |
10 | 45 | 94 | Primary | YP | 12 | 11.65 | 0.63 | NLP | No | Yes | Yes | No | No | RD+PVR | |
11 | 51 | 93 | Primary | YP | 6 | 8 | 0.63 | HM | No | No | No | No | No | RD | |
12 | 49 | 92 | Primary | YP | 13.5 | 11.7 | 0.125 | CF | No | No | No | No | No | No | |
13 | 35 | 91 | Primary | IN | 8.5 | 13.5 | 0.1 | HM | No | No | No | No | No | No | |
14 | 42 | 88 | Primary | IT | 10 | 9.8 | 0.063 | 0.05 | No | No | No | No | No | SRNM | |
15 | 77 | 81 | Primary | SN | 7.7 | 8.2 | 0.32 | CF | No | No | No | No | No | No | |
16 | 60 | 74 | Salvage | IN | 6.56 | 4.67 | CF | CF | No | No | No | No | No | ERM | |
17 | 43 | 63 | Primary | T | 12.1 | 9.6 | 0.63 | NLP | No | Yes | Yes | Yes | Yes | Phthisis | |
18 | 57 | 63 | Salvage | ST | 8.75 | 9.73 | 0.67 | CF | No | No | No | No | No | PRR | |
19 | 53 | 62 | Primary | ST | 9.5 | 8 | 0.32 | 0.05 | No | No | No | No | No | PRR | |
20 | 46 | 62 | Primary | T | 10 | 9.9 | 0.1 | CF | No | No | No | No | No | ERM | |
21 | 59 | 60 | Salvage | IN | 10.7 | 7.09 | 0.2 | CF | No | No | No | Yes | Yes | No | |
22 | 60 | 60 | Primary | T | 15 | 12 | 0.9 | 0.67 | Yes | No | No | No | No | No | |
23 | 56 | 58 | Primary | IT | 10 | 11 | 0.63 | CF | No | No | No | No | No | RD | |
24 | 76 | 57 | Primary | T | 12.26 | 9 | HM | 0.32 | No | No | No | No | No | No | |
25 | 62 | 56 | Primary | N | 13 | 13 | 0.2 | HM | Yes | No | No | No | No | Subretinal fibrosis | |
26 | 29 | 53 | Primary | I | 10 | 8.3 | 0.063 | CF | Yes | No | No | No | No | No | |
27 | 43 | 50 | Primary | S | 11 | 11 | 0.63 | 0.2 | Yes | No | No | No | No | No | |
28 | 38 | 45 | Primary | T | 10.8 | 11.53 | 0.32 | CF | Yes | No | No | No | No | RD+PVR | |
29 | 58 | 45 | Primary | ST | 6 | 8 | 0.5 | CF | Yes | No | No | No | No | No | |
30 | 49 | 45 | Primary | T | 8 | 8.36 | 0.063 | LP | Yes | No | No | No | No | RD | |
31 | 21 | 43 | Primary | T | 12 | 8 | 0.5 | CF | Yes | No | No | No | No | RD+PVR | |
32 | 61 | 42 | Primary | S | 5 | 8.2 | 0.05 | LP | Yes | No | No | No | No | No | |
33 | 56 | 39 | Primary | ST | 7.7 | 7.7 | 0.63 | HM | No | No | No | Yes | Yes | Colon carcinoma with metastasis | RD |
34 | 63 | 39 | Salvage | T | 10 | 5 | 0.1 | CF | No | No | No | No | No | No | |
35 | 26 | 34 | Primary | T | 12 | 9.5 | 0.5 | HM | Yes | No | No | No | No | RD+PVR | |
36 | 49 | 34 | Primary | T | 6.6 | 12 | CF | LP | Yes | No | No | No | No | No | |
37 | 51 | 23 | Primary | T | 12 | 8 | CF | CF | Yes | No | No | No | No | No | |
38 | 62 | 23 | Primary | YP | 6.4 | 9.7 | 0.32 | HM | Yes | No | No | No | No | Corneal decompensation |
CF, counting fingers; ERM, epiretinal membrane; HM, hand motion; I, inferior; IN, inferonasal; IT, inferotemporal; LP, light perception; N, nasal; NLP, no light perception; PRR, postradiation retinopathy; PVR, proliferative vitreoretinopathy; RD, retinal detachment; S, superior; SN, superonasal; SRNM, subretinal neovascular membrane; ST, superotemporal; T, temporal; VA, visual acuity.